Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS

Clinical trial NCT03520517 · COMPLETED

Trial details

NCT number: NCT03520517
Sponsor: Biohaven Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis ALS Lou Gehrig Disease Lou Gehrig's Disease Lou-Gehrigs Disease Motor Neuron Disease, Amyotrophic Lateral Sclerosis

Start date: 2018-02-02
Primary completion: 2018-10-08
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.